X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

May 14, 2019

Industry Trends in China: The Generic Consistency Evaluation

In China, the industrial and regulatory landscape has been evolving rapidly – and in particular as it relates to generic drug products. In 2015, the China State Council announced Opinions on Reforming the Review and Approval System for Drugs and Medical Devices (No. 44). At this same time, a series of reforms were announced by the National Drug Administration of China (formerly the China Food and Drug Administration, CFDA) to upgrade the pharmaceutical industry by raising marketed products to international standards in terms of quality, safety and efficacy.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    SmartDose In-Use

    May 07, 2019

    The Impact Poor Formulations Have on Drug Development Programs

    Victoria Morgan

    Victoria Morgan

    Director, Segment Marketing, Global Biologics

    SmartDose Platform

    April 26, 2019

    Overcoming Challenges Associated with Biologic Drug Formulation and Development

    Victoria Morgan

    Victoria Morgan

    Director, Segment Marketing, Global Biologics

    Load more